MicroRNA targeting: A novel therapeutic intervention for ovarian cancer

被引:7
|
作者
Asl, Elmira Roshani [1 ]
Sarabandi, Sajed [2 ]
Shademan, Behrouz [3 ]
Dalvandi, Kourosh [4 ]
Sheikhansari, Golshan [5 ]
Nourazarian, Alireza [6 ]
机构
[1] Saveh Univ Med Sci, Social Determinants Hlth Res Ctr, Saveh, Iran
[2] Islamic Azad Univ Karaj, Fac Med Sci, Dept Vet, Karaj, Iran
[3] Tabriz Univ Med Sci, Stem Cell Res Ctr, Tabriz, Iran
[4] Minist Hlth & Med Educ, Hlth Dept, Tehran, Iran
[5] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran
[6] Khoy Univ Med Sci, Dept Basic Med Sci, Khoy, Iran
关键词
Ovarian cancer; microRNA; Prognostics; Biomarker; Diagnostic biomarker; Therapeutic strategy; MESSENGER-RNAS; BREAST-CANCER; HEPATITIS-C; EXPRESSION; BIOMARKER; FAMILY; PROGRESSION; MECHANISMS; DIAGNOSIS; SEQUENCE;
D O I
10.1016/j.bbrep.2023.101519
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ovarian cancer, a perilous form of cancer affecting the female reproductive system, exhibits intricate communication networks that contribute to its progression. This study aims to identify crucial molecular abnormalities linked to the disease to enhance diagnostic and therapeutic strategies. In particular, we investigate the role of microRNAs (miRNAs) as diagnostic biomarkers and explore their potential in treating ovarian cancer. By targeting miRNAs, which can influence multiple pathways and genes, substantial therapeutic benefits can be attained. In this review we want to shed light on the promising application of miRNA-based interventions and provide insights into the specific miRNAs implicated in ovarian cancer pathogenesis.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] MicroRNA-135a-3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer
    Fukagawa, Satoshi
    Miyata, Kohei
    Yotsumoto, Fusanori
    Kiyoshima, Chihiro
    Nam, Sung Ouk
    Anan, Haruchika
    Katsuda, Takahiro
    Miyahara, Daisuke
    Murata, Masaharu
    Yagi, Hiroshi
    Shirota, Kyoko
    Yasunaga, Shin'ichiro
    Kato, Kiyoko
    Miyamoto, Shingo
    CANCER SCIENCE, 2017, 108 (05) : 886 - 896
  • [42] MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer
    Gao, Ying-chun
    Wu, Jie
    TUMOR BIOLOGY, 2015, 36 (06) : 4843 - 4850
  • [43] The potential role of exosomes derived from ovarian cancer cells for diagnostic and therapeutic approaches
    Yang, Changwon
    Kim, Hee Seung
    Song, Gwonhwa
    Lim, Whasun
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (12) : 21493 - 21503
  • [44] Targeting miRNAs by polyphenols: Novel therapeutic strategy for cancer
    Devi, Kasi Pandima
    Rajavel, Tamilselvam
    Daglia, Maria
    Nabavi, Seyed Fazel
    Bishayee, Anupam
    Nabavi, Seyed Mohammad
    SEMINARS IN CANCER BIOLOGY, 2017, 46 : 146 - 157
  • [45] Targeting human caseinolytic protease P (ClpP) as a novel therapeutic strategy in ovarian cancer
    Luo, Baozhu
    Zhang, Jiangnan
    Qiao, Wenliang
    Zhou, Yuanzhen
    Huang, Jiasheng
    Yang, Tao
    Luo, Youfu
    MEDCOMM-ONCOLOGY, 2022, 1 (01):
  • [46] Mechanisms and Therapeutic Targets of microRNA-associated Chemoresistance in Epithelial Ovarian Cancer
    Zhang, Lingyun
    Nadeem, Lubna
    Connor, Kristin
    Xu, Guoxiong
    CURRENT CANCER DRUG TARGETS, 2016, 16 (05) : 429 - 441
  • [47] MicroRNA-21 A novel therapeutic target in human cancer
    Pan, Xuan
    Wang, Zhao-Xia
    Wang, Rui
    CANCER BIOLOGY & THERAPY, 2010, 10 (12) : 1224 - 1232
  • [48] A urinary microRNA (miR) signature for diagnosis of bladder cancer
    Hofbauer, Sebastian L.
    de Martino, Michela
    Lucca, Ilaria
    Haitel, Andrea
    Susani, Martin
    Shariat, Shahrokh F.
    Klatte, Tobias
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (12) : 531.e1 - 531.e8
  • [49] microRNA-488 inhibits chemoresistance of ovarian cancer cells by targeting Six1 and mitochondrial function
    Yang, Zhuo
    Feng, Ziyi
    Gu, JiaHui
    Li, XinHui
    Dong, QianZhe
    Liu, KuiRan
    Li, Yan
    OuYang, Ling
    ONCOTARGET, 2017, 8 (46) : 80981 - 80993
  • [50] The significance of microRNA deregulation in colorectal cancer development and the clinical uses as a diagnostic and prognostic biomarker and therapeutic agent
    Ahadi, Alireza
    NON-CODING RNA RESEARCH, 2020, 5 (03): : 125 - 134